Disease on EC 2.7.4.14 - UMP/CMP kinase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
5'-nucleotidase deficiency
Pyrimidine nucleoside monophosphate kinase hyperactivity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
Breast Neoplasms
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.
Carcinoma, Hepatocellular
Differences between pyrimidine nucleoside monophosphate kinase from rat Novikoff ascites hepatoma and rat liver.
Pyrimidine nucleoside monophosphate kinase from rat liver and rat Novikoff ascites hepatoma (EC 2.7.4.14).
Carcinoma, Non-Small-Cell Lung
Differential Effect of Polymorphisms of CMPK1 and RRM1 on Survival in Advanced Non-small Cell Lung Cancer Patients Treated with Gemcitabine or Taxane/Cisplatinum.
Carcinoma, Ovarian Epithelial
Cytidine monophosphate kinase is inhibited by the TGF-? signalling pathway through the upregulation of miR-130b-3p in human epithelial ovarian cancer.
Data on the association of CMPK1 with clinicopathological features and biological effect in human epithelial ovarian cancer.
Hepatitis B, Chronic
MiR-3613-3p impairs IFN-induced immune response by targeting CMPK1 in chronic hepatitis B.
Infections
Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells.
Leukemia
Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondria.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondria.
Lung Neoplasms
Comprehensive evaluation of the response of genes to the administration of the antitumor drug S-1 using a low density array.
Differential Effect of Polymorphisms of CMPK1 and RRM1 on Survival in Advanced Non-small Cell Lung Cancer Patients Treated with Gemcitabine or Taxane/Cisplatinum.
Neoplasm Metastasis
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.
Neoplasms
Cytidine monophosphate kinase is inhibited by the TGF-? signalling pathway through the upregulation of miR-130b-3p in human epithelial ovarian cancer.
Data on the association of CMPK1 with clinicopathological features and biological effect in human epithelial ovarian cancer.
Differences between pyrimidine nucleoside monophosphate kinase from rat Novikoff ascites hepatoma and rat liver.
Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondria.
Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine.
Micropreparative immobilized pH gradient two-dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondria.
Stroke
Characterization of the rat cerebrospinal fluid proteome following acute cerebral ischemia using an aptamer-based proteomic technology.
Triple Negative Breast Neoplasms
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.
Tuberculosis
Insight from the structural molecular model of cytidylate kinase from Mycobacterium tuberculosis.
Kinetic mechanism and energetics of binding of phosphoryl group acceptors to Mycobacterium tuberculosis cytidine monophosphate kinase.
Molecular modeling and dynamics studies of cytidylate kinase from Mycobacterium tuberculosis H37Rv.
Mycobacterium Cytidylate Kinase Appears to Be an Undruggable Target.
The Rv1712 Locus from Mycobacterium tuberculosis H37Rv codes for a functional CMP kinase that preferentially phosphorylates dCMP.